Parthenon LLC’s Bristol-Myers Squibb BMY Stock Holding History

Parthenon LLC’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-4,023	Closed	-$206K	–	123
2023 Q4	$206K	Hold	4,023	–	–	0.03%	117
2023 Q3	$233K	Hold	4,023	–	–	0.04%	109
2023 Q2	$257K	Sell	4,023 -5,829	-59%	-$391K	0.04%	106
2023 Q1	$683K	Hold	9,852	–	–	0.1%	79
2022 Q4	$709K	Hold	9,852	–	–	0.12%	74
2022 Q3	$700K	Sell	9,852 -849	-8%	-$61.6K	0.13%	75
2022 Q2	$824K	Hold	10,701	–	–	0.14%	74
2022 Q1	$781K	Hold	10,701	–	–	0.11%	78
2021 Q4	$667K	Hold	10,701	–	–	0.09%	83
2021 Q3	$633K	Sell	10,701 -576	-5%	-$37.9K	0.1%	82
2021 Q2	$754K	Buy	11,277 +576	+5%	+$37.6K	0.11%	79
2021 Q1	$676K	Hold	10,701	–	–	0.11%	77
2020 Q4	$664K	Buy	10,701 +300	+3%	+$18.4K	0.11%	78
2020 Q3	$627K	Hold	10,401	–	–	0.12%	78
2020 Q2	$612K	Hold	10,401	–	–	0.13%	75
2020 Q1	$580K	Hold	10,401	–	–	0.14%	75
2019 Q4	$668K	Buy	10,401 +1,000	+11%	+$57.3K	0.13%	73
2019 Q3	$477K	Hold	9,401	–	–	0.1%	80
2019 Q2	$426K	Hold	9,401	–	–	0.09%	82
2019 Q1	$449K	Hold	9,401	–	–	0.1%	82
2018 Q4	$489K	Hold	9,401	–	–	0.12%	79
2018 Q3	$584K	Sell	9,401 -1,239	-12%	-$73.5K	0.13%	78
2018 Q2	$589K	Hold	10,640	–	–	0.14%	81
2018 Q1	$673K	Hold	10,640	–	–	0.16%	75
2017 Q4	$652K	Hold	10,640	–	–	0.15%	78
2017 Q3	$678K	Hold	10,640	–	–	0.16%	75
2017 Q2	$593K	Hold	10,640	–	–	0.14%	79
2017 Q1	$579K	Buy	10,640 +125	+1%	+$6.86K	0.14%	81
2016 Q4	$614K	Sell	10,515 -500	-5%	-$27.3K	0.15%	79
2016 Q3	$594K	Hold	11,015	–	–	0.15%	79
2016 Q2	$810K	Hold	11,015	–	–	0.2%	69
2016 Q1	$704K	Hold	11,015	–	–	0.18%	71
2015 Q4	$758K	Hold	11,015	–	–	0.2%	72
2015 Q3	$652K	Hold	11,015	–	–	0.18%	73
2015 Q2	$733K	Buy	11,015 +300	+3%	+$19.8K	0.19%	72
2015 Q1	$691K	Hold	10,715	–	–	0.18%	72
2014 Q4	$633K	Buy	10,715 +200	+2%	+$11.3K	0.17%	67
2014 Q3	$538K	Hold	10,515	–	–	0.16%	68
2014 Q2	$510K	Sell	10,515 -3,461	-25%	-$171K	0.15%	67
2014 Q1	$726K	Hold	13,976	–	–	0.22%	61
2013 Q4	$743K	Hold	13,976	–	–	0.23%	59
2013 Q3	$647K	Sell	13,976 -369	-3%	-$16.2K	0.21%	62
2013 Q2	$641K	Buy	+14,345	New	+$623K	0.22%	58

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Parthenon LLC's BMY Position: Q1 2024 in Review

Parthenon LLC sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 4,023 shares — an estimated $206K sold.

Parthenon LLC first reported a position in BMY in Q2 2013 and held it in 43 quarters. The position peaked at $824K in Q2 2022. 2,332 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

Parthenon LLC reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
Parthenon LLC sold 4,023 Bristol-Myers Squibb shares in Q1 2024, an estimated $206K.
Parthenon LLC first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 43 quarters.
Parthenon LLC's Bristol-Myers Squibb position peaked at $824K in Q2 2022.
2,332 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on Parthenon LLC's 13F filing for Q1 2024, filed 30 Apr 2024.